• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

水通道蛋白4与帕金森病

Aquaporin-4 and Parkinson's Disease.

作者信息

Lapshina Ksenia V, Ekimova Irina V

机构信息

Laboratory of Comparative Thermophysiology, Sechenov Institute of Evolutionary Physiology and Biochemistry of RAS, 194223 Saint Petersburg, Russia.

出版信息

Int J Mol Sci. 2024 Jan 30;25(3):1672. doi: 10.3390/ijms25031672.

DOI:10.3390/ijms25031672
PMID:38338949
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10855351/
Abstract

The water-selective channel aquaporin-4 (AQP4) is implicated in water homeostasis and the functioning of the glymphatic system, which eliminates various metabolites from the brain tissue, including amyloidogenic proteins. Misfolding of the α-synuclein protein and its post-translational modifications play a crucial role in the development of Parkinson's disease (PD) and other synucleopathies, leading to the formation of cytotoxic oligomers and aggregates that cause neurodegeneration. Human and animal studies have shown an interconnection between AQP4 dysfunction and α-synuclein accumulation; however, the specific role of AQP4 in these mechanisms remains unclear. This review summarizes the current knowledge on the role of AQP4 dysfunction in the progression of α-synuclein pathology, considering the possible effects of AQP4 dysregulation on brain molecular mechanisms that can impact α-synuclein modification, accumulation and aggregation. It also highlights future directions that can help study the role of AQP4 in the functioning of the protective mechanisms of the brain during the development of PD and other neurodegenerative diseases.

摘要

水选择性通道水通道蛋白4(AQP4)与水稳态以及类淋巴系统的功能有关,该系统可清除脑组织中的各种代谢产物,包括淀粉样蛋白。α-突触核蛋白的错误折叠及其翻译后修饰在帕金森病(PD)和其他突触核蛋白病的发展中起关键作用,导致细胞毒性寡聚体和聚集体的形成,进而引起神经退行性变。人类和动物研究表明AQP4功能障碍与α-突触核蛋白积累之间存在关联;然而,AQP4在这些机制中的具体作用仍不清楚。本综述总结了目前关于AQP4功能障碍在α-突触核蛋白病理学进展中作用的知识,考虑了AQP4失调对可能影响α-突触核蛋白修饰、积累和聚集的脑分子机制的潜在影响。它还强调了未来的研究方向,这些方向有助于研究AQP4在PD和其他神经退行性疾病发展过程中脑保护机制功能中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d139/10855351/dcaa7a3dcc41/ijms-25-01672-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d139/10855351/dcaa7a3dcc41/ijms-25-01672-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d139/10855351/dcaa7a3dcc41/ijms-25-01672-g001.jpg

相似文献

1
Aquaporin-4 and Parkinson's Disease.水通道蛋白4与帕金森病
Int J Mol Sci. 2024 Jan 30;25(3):1672. doi: 10.3390/ijms25031672.
2
Decreased AQP4 Expression Aggravates ɑ-Synuclein Pathology in Parkinson's Disease Mice, Possibly via Impaired Glymphatic Clearance.AQP4 表达降低加重帕金森病小鼠的ɑ-突触核蛋白病理学,可能通过损害神经胶质淋巴清除。
J Mol Neurosci. 2021 Dec;71(12):2500-2513. doi: 10.1007/s12031-021-01836-4. Epub 2021 Mar 26.
3
α-Synuclein pathology in Parkinson's disease and related α-synucleinopathies.帕金森病及相关α-突触核蛋白病中的α-突触核蛋白病理学。
Neurosci Lett. 2019 Sep 14;709:134316. doi: 10.1016/j.neulet.2019.134316. Epub 2019 Jun 3.
4
Expression of Aquaporin 1 and Aquaporin 4 in the Temporal Neocortex of Patients with Parkinson's Disease.帕金森病患者颞叶新皮质中水通道蛋白1和水通道蛋白4的表达
Brain Pathol. 2017 Mar;27(2):160-168. doi: 10.1111/bpa.12369. Epub 2016 Apr 6.
5
Interaction Between the Glymphatic System and α-Synuclein in Parkinson's Disease.帕金森病中类淋巴系统与α-突触核蛋白之间的相互作用
Mol Neurobiol. 2023 Apr;60(4):2209-2222. doi: 10.1007/s12035-023-03212-2. Epub 2023 Jan 13.
6
An Update on the Critical Role of α-Synuclein in Parkinson's Disease and Other Synucleinopathies: from Tissue to Cellular and Molecular Levels.α-突触核蛋白在帕金森病和其他突触核蛋白病中的关键作用的最新研究进展:从组织到细胞和分子水平。
Mol Neurobiol. 2022 Jan;59(1):620-642. doi: 10.1007/s12035-021-02596-3. Epub 2021 Nov 8.
7
Post-translational modification of α-synuclein in Parkinson's disease.帕金森病中α-突触核蛋白的翻译后修饰
Brain Res. 2015 Dec 2;1628(Pt B):247-253. doi: 10.1016/j.brainres.2015.06.002. Epub 2015 Jun 14.
8
Aquaporin 4: A key player in Parkinson's disease.水通道蛋白 4:帕金森病的关键因素。
J Cell Physiol. 2019 Dec;234(12):21471-21478. doi: 10.1002/jcp.28871. Epub 2019 May 24.
9
Aquaporin-4 deficiency reduces TGF-β1 in mouse midbrains and exacerbates pathology in experimental Parkinson's disease.水通道蛋白-4 缺乏减少了实验性帕金森病中小脑中的 TGF-β1,并加重了其病理学改变。
J Cell Mol Med. 2019 Apr;23(4):2568-2582. doi: 10.1111/jcmm.14147. Epub 2019 Jan 25.
10
Aquaporin-4 mis-localization slows glymphatic clearance of α-synuclein and promotes α-synuclein pathology and aggregate propagation.水通道蛋白4定位错误会减缓α-突触核蛋白的类淋巴清除,并促进α-突触核蛋白病变和聚集体传播。
bioRxiv. 2024 Aug 19:2024.08.14.607971. doi: 10.1101/2024.08.14.607971.

引用本文的文献

1
The Role of Aquaporin-4 in Freezing of Gait and Dynamic Balance Learning in Parkinson's Disease.水通道蛋白4在帕金森病步态冻结和动态平衡学习中的作用
Sci Rep. 2025 Aug 30;15(1):31949. doi: 10.1038/s41598-025-15161-y.
2
The Cerebral Lymphatic System: Function, Controversies, and Therapeutic Approaches for Central Nervous System Diseases.脑淋巴系统:中枢神经系统疾病的功能、争议及治疗方法
Cell Mol Neurobiol. 2025 Aug 19;45(1):80. doi: 10.1007/s10571-025-01598-2.
3
The role of brain-liver-gut Axis in neurological disorders.脑-肝-肠轴在神经疾病中的作用。

本文引用的文献

1
TRPV4-mediated Ca deregulation causes mitochondrial dysfunction via the AKT/α-synuclein pathway in dopaminergic neurons.瞬时受体电位香草酸亚型4(TRPV4)介导的钙调节异常通过多巴胺能神经元中的AKT/α-突触核蛋白途径导致线粒体功能障碍。
FASEB Bioadv. 2023 Oct 11;5(12):507-520. doi: 10.1096/fba.2023-00057. eCollection 2023 Dec.
2
Mechanisms of Activation of Brain's Drainage during Sleep: The Nightlife of Astrocytes.脑在睡眠时引流的激活机制:星形胶质细胞的夜生活。
Cells. 2023 Nov 20;12(22):2667. doi: 10.3390/cells12222667.
3
Melatonin alleviates depression-like behaviors and cognitive dysfunction in mice by regulating the circadian rhythm of AQP4 polarization.
Burns Trauma. 2025 May 2;13:tkaf011. doi: 10.1093/burnst/tkaf011. eCollection 2025.
4
Clinical and brain volumetric correlates of decreased DTI-ALPS, suggestive of local glymphatic dysfunction, in iRBD.快速眼动期行为障碍(iRBD)中DTI-ALPS降低的临床和脑容量相关性,提示局部类淋巴系统功能障碍
NPJ Parkinsons Dis. 2025 Apr 23;11(1):87. doi: 10.1038/s41531-025-00942-z.
5
Intranasal administration of tissue inhibitor of metalloproteinase 1 extracted from stem cells from human exfoliated deciduous teeth-conditioned medium improves neurological outcomes and alpha-synuclein elimination in Parkinson's disease mice.经鼻给予从人脱落乳牙干细胞条件培养基中提取的金属蛋白酶组织抑制剂1可改善帕金森病小鼠的神经功能结果并促进α-突触核蛋白清除。
J Dent Sci. 2025 Apr;20(2):1043-1051. doi: 10.1016/j.jds.2024.11.029. Epub 2024 Dec 12.
6
Glymphatic dysfunction exacerbates cognitive decline by triggering cortical degeneration in Parkinson's disease: evidence from diffusion-tensor MRI.类淋巴系统功能障碍通过引发帕金森病中的皮质变性加剧认知衰退:来自扩散张量磁共振成像的证据
Brain Commun. 2025 Feb 20;7(1):fcaf029. doi: 10.1093/braincomms/fcaf029. eCollection 2025.
7
Functional abnormalities of the glymphatic system in cognitive disorders.认知障碍中类淋巴系统的功能异常。
Neural Regen Res. 2025 Dec 1;20(12):3430-3447. doi: 10.4103/NRR.NRR-D-24-01049. Epub 2025 Jan 13.
8
Targeting the glymphatic system to promote α-synuclein clearance: a novel therapeutic strategy for Parkinson's disease.靶向类淋巴系统促进α-突触核蛋白清除:帕金森病的一种新治疗策略。
Neural Regen Res. 2025 Jan 13;21(1):233-47. doi: 10.4103/NRR.NRR-D-24-00764.
9
Neurovascular unit, neuroinflammation and neurodegeneration markers in brain disorders.脑部疾病中的神经血管单元、神经炎症和神经退行性变标志物
Front Cell Neurosci. 2024 Oct 25;18:1491952. doi: 10.3389/fncel.2024.1491952. eCollection 2024.
褪黑素通过调节 AQP4 极化的昼夜节律来缓解小鼠的抑郁样行为和认知功能障碍。
Transl Psychiatry. 2023 Oct 6;13(1):310. doi: 10.1038/s41398-023-02614-z.
4
AQP4-independent TRPV4 modulation of plasma membrane water permeability.不依赖水通道蛋白4(AQP4)的瞬时受体电位香草酸亚型4(TRPV4)对质膜水通透性的调节
Front Cell Neurosci. 2023 Aug 31;17:1247761. doi: 10.3389/fncel.2023.1247761. eCollection 2023.
5
Myo1d promotes alpha-synuclein transfer from brain microvascular endothelial cells to pericytes through tunneling nanotubes.肌球蛋白1d通过隧道纳米管促进α-突触核蛋白从脑微血管内皮细胞向周细胞的转移。
iScience. 2023 Jul 22;26(8):107458. doi: 10.1016/j.isci.2023.107458. eCollection 2023 Aug 18.
6
α-Synuclein Aggregation Is Triggered by Oligomeric Amyloid-β 42 via Heterogeneous Primary Nucleation.α-突触核蛋白聚集是由寡聚态淀粉样-β 42 通过异质成核引发的。
J Am Chem Soc. 2023 Aug 23;145(33):18276-18285. doi: 10.1021/jacs.3c03212. Epub 2023 Aug 9.
7
In vivo effects of the alpha-synuclein misfolding inhibitor minzasolmin supports clinical development in Parkinson's disease.α-突触核蛋白错误折叠抑制剂明扎索尔明的体内效应支持帕金森病的临床开发。
NPJ Parkinsons Dis. 2023 Jul 17;9(1):114. doi: 10.1038/s41531-023-00552-7.
8
Are Therapies That Target α-Synuclein Effective at Halting Parkinson's Disease Progression? A Systematic Review.靶向α-突触核蛋白的疗法能否有效阻止帕金森病进展?系统评价。
Int J Mol Sci. 2023 Jul 3;24(13):11022. doi: 10.3390/ijms241311022.
9
Targeted degradation of ⍺-synuclein aggregates in Parkinson's disease using the AUTOTAC technology.利用 AUTOTAC 技术靶向降解帕金森病中的 ⍺-突触核蛋白聚集物。
Mol Neurodegener. 2023 Jun 24;18(1):41. doi: 10.1186/s13024-023-00630-7.
10
Monitoring α-synuclein ubiquitination dynamics reveals key endosomal effectors mediating its trafficking and degradation.监测α-突触核蛋白泛素化动力学揭示了介导其运输和降解的关键内体效应因子。
Sci Adv. 2023 Jun 16;9(24):eadd8910. doi: 10.1126/sciadv.add8910. Epub 2023 Jun 14.